Cleantech Transit, Inc. (CLNO)
Cleantech Transit, Inc. is in the business of producing and conserving power. They produce and sell clean electricity globally, with a focus on sustainable energies using renewable resources such as Geothermal, Solar and Wind. Cleantech Transit, Inc goal is to use innovative technologies to reduce electricity consumption and dependence on carbon based energy.
Biomass fuel refers to any source of organic material. Organic material is created through the life that exists on earth be it animal or plant. For the majority of Biomass Fuel power plants the main fuel source is plant material.
The sun is a massive nuclear reactor giving off vast amounts of light and heat energy. Life on Earth uses this source of energy to thrive by transforming the suns energy in to cell growth and reproduction. Trees for example grow and produce leaves that harvest and use the suns energy to photosynthesis and thus produce energy for growing and creating new cells as part of the tree structure growing new branches for further harvesting and increasing their trunk size to accommodate more branches and more energy sources.
Cleantech Transit Inc. was founded to capitalize on technology advances and manufacturing opportunities in the growing clean energy public transportation sector. The Company has expanded its focus to invest directly in specific green projects. Recognizing the many economic and operational advances of converting wood waste into renewable sources of energy, Cleantech has selected to invest in Phoenix Energy (www.phoenixenergy.net). This project could benefit the Company’s manufacturing clients worldwide.
Cleantech Transit Inc. is pleased to provide additional details after achieving success on the 500 KW facility and successfully moving past the interconnection testing stage.
Coming on the recent success at the 500KW facility in Merced, California this poises Phoenix Energy to become a leading developer of renewable biomass distributed generation plants that utilize local resources for local energy.
Currently there are two additional projects being pre-certified by Phoenix Energy in California. The projects are each projected to be 1 MW biomass gasification facilities that will provide both electricity and process heat energy. Each facility will provide enough electricity to power approximately 800 homes as well as process heat to be used in drying agricultural products. The projects are expected to complete by the end of 2012.
Cleantech will be providing details on the expecting closing date of its initial investment into Phoenix Energy in the coming weeks.
For more information about Cleantech Transit, Inc. visit its website www.cleantechtransitinc.com
Power3 Medical Products, Inc (PWRM)
Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease).
Power3 applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 has developed a portfolio of products including BC-SeraPro�, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro�, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual’s proteins to detect the presence of disease, a patient’s disease progression, a patient’s response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.
Parkinson’s disease (PD) is an age-related deterioration of certain nerve systems, which affects your movement, balance, and muscle control.
Parkinson’s disease is one of the most common movement disorders, affecting 1% of people older than 60 years. PD is about 1.5 times more common in men than in women, and it becomes more common as you age. In PD, brain cells deteriorate (or degenerate) in an area of the brain called the substantia nigra. From the substantia nigra, specific nerve cell tracts connect to another part of the brain called the corpus striatum, where the neurotransmitter (a chemical messenger in the brain) called dopamine is released. Dopamine is an important neurotransmitter and alterations in its concentration can lead to different medical problems.
The loss of these specific brain cells and decline in dopamine concentration are the cornerstone of signs and symptoms of PD as well as the target for treatment. The biological mechanism responsible for the brain cell loss has not been identified.
Power3 Medical Products, Inc is a breakthrough proteomics company specializing in the identification of disease footprints in the areas of chemotherapeutic drug resistance and the early detection of breast cancer and neurological diseases. The research platform is centered on the study of proteomics, the science of protein interactions within living cells. With a combined 50+ years of proteomic experience, the Company has identified 334 protein biomarkers with the following potential medical applications:
1) Breast Cancer 5) Chemotherapeutic Drug Resistance
2) Alzheimer’s Disease 6) Leukemia
3) ALS (Lou Gehrig’s Disease) 7) Gastrointestinal Disease
4) Parkinson’s Disease 8)Metabolic Syndrome
5)
For more information about Power3 Medical Products, Inc. please visit http://www.power3medical.com
Fortress Investment Group LLC (NYSE:FIG) announced that Daniel Mudd, Fortress Chief Executive Officer, is scheduled to present at the KBW 2011 Investment Management & Specialty Finance Conference at the St. Regis Hotel in New York City on Tuesday, June 7, 2011, at 9:30 a.m. (Eastern Time). A live audio webcast of Mr. Mudd’s presentation, including related materials, will be available on the Investor Relations section of Fortress’s website at www.fortress.com. The audio replay of the webcast and presentation will be available online through Tuesday, June 21, 2011.
Fortress Investment Group LLC is a public investment firm specializing in investments in debt and equity securities of public and privately held companies.
Graphic Packaging Holding Company (NYSE:GPK) announced on May 23, 2011 that David A. Perdue has been appointed to the Company’s Board of Directors, which was become effective May 19, 2011. Mr. Perdue was also appointed as a member of the Compensation and Benefits Committee. “We are very pleased to welcome David to the Board of Graphic Packaging,” said John Miller, chairman of the board. “His extensive corporate experience and financial background will serve both the board and the committee well as we work to further the Company’s priorities.”
Graphic Packaging Holding Company, together with its subsidiaries, provides packaging solutions in the United States, Canada, Central/South America, Europe, and the Asia-Pacific.
Luby’s Inc. (NYSE:LUB) announced that it will release its fiscal third quarter results on Wednesday, June 8, 2011 after the market closes. In conjunction with the release, Luby’s has scheduled a conference call, which will be broadcast live over the Internet, on Thursday, June 9, 2011 at 10:00 a.m. Central time.
Luby’s, Inc., together with its subsidiaries, engages in the ownership and operation of restaurants in the United States.
No comments:
Post a Comment